IL1B and colitis: Oral administration of NK151, NK175, or their (4:1) mix suppressed cGm-induced colitis in mice: they suppressed colonic myeloperoxidase activity, IL-1β and IL-6 expression, and the NF-κB+CD11c+ cell population, while significantly increasing IL-10 expression (Figure 8E).